HYPERBARIC (HBOT)

About HYPERBARIC (HBOT)

What is Hyperbaric Oxygenation?

Hyperbaric Oxygenation therapy is a treatment that involves the breathing in of pure oxygen while in a pressurized room or tube.

Hyperbaric oxygen therapy (HBOT) is a form of treatment in which a patient breathes 100% oxygen at pressure greater than 1 atmospheric pressure (ATA). In an HBOT chamber, the air pressure is three times higher than the normal air pressure. Under these conditions, your lungs can gather more oxygen than would be possible breathing pure oxygen at normal air pressure. The oxygen is then carried through your blood around your body which stimulates the release of substance called growth factors and stem cells which boost the body’s ability to heal. The aim of the treatment is to increase the O2 level dissolved in the plasma up to 15 times the normal amounts, which helps in treatment of many diseases.

HBOT therapy is a vastly established treatment for Decompressive (diving) sickness and Carbon Monoxide poisoning, however in recent years it has been widely used as treatment across a wide range of illnesses.

At AZHD we use Hyperbaric Oxygenation to treat the following conditions
  1. Diabetic wounds
  2. Non healing ulcers
  3. Bed sores, Burn
  4. After radiation therapy
  5. Traumatic wounds
  6. Hearing & vision loss
  7. Bone infections
  8. Plastic Surgery Recovery
  9. Stroke
  10. Sport injuries
  11. Carbon monoxide poisoning and many other diseases
Central Nervous System
Open visitation with only two visitors in a room at any given time. No one under 12 years of age may.
Allergic Disorders
Open visitation with only two visitors in a room at any given time. No one under 12 years of age may.
Neoplastic Disorders
Open visitation with only two visitors in a room at any given time. No one under 12 years of age may.

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

Drug discovery and drug development are complex and expensive endeavors undertaken by pharmaceutical companies, academic scientists, and governments. As a result of this complex path from discovery to commercialization, partnering has become a standard practice for advancing drug candidates through development pipelines. Governments generally regulate what drugs can be marketed, how drugs are marketed, and in some jurisdictions,

Chest CT Scan

Although pulmonary medicine only began to evolve as a medical specialty in the 1950s, William Welch and William Osler founded the ‘parent’ organization of the American Thoracic Society

One of the first major discoveries relevant to the field of pulmonology was the discovery of pulmonary circulation. Originally, it was thought that blood reaching the right side of the heart passed through small ‘pores’ in the septum into the left side to be oxygenated, as theorized by Galen; however, the discovery of pulmonary circulation disproves this theory, which had previously been accepted since the 2nd century. Thirteenth century anatomist and physiologist Ibn Al-Nafis accurately theorized that there was no ‘direct’ passage between the two sides.

Our team of highly qualified and experienced physicians drawn from across the world.

Book an appointment with one of our HYPERBARIC (HBOT) doctors

We will send you a confirmation within 24 hours. Emergency? Call +971 4 378 6666

Other Specialties

Meet Our Doctors